PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In high-fat fed mice, seed oil significantly decreased low-density lipoprotein (LDL), total cholesterol (TC), and triglycerides (TG), while increasing high-density lipoprotein (HDL) [PMID:35745155]
In rats with CCl4-induced oxidative damage, tea seed oil lowered serum hepatic enzyme markers (ALT, AST, LDH), inhibited fatty degeneration, and reduced malondialdehyde [PMID:17188414]
Tea seed oil exhibited inhibitory activity on melanogenesis by inhibiting tyrosinase [PMID:29071231]
Specific sapogenins (camelliagnin A and a novel metabolite a2) demonstrated significant inhibitory effects on LPS and HMGB1-induced inflammation [PMID:38553195]
Evidence summary
PubMed sources
- 1.PMID: 40540300 (2026) — Camellia oleifera oil: unveiling health benefits and exploring novel applications. · Critical reviews in food science and nutrition
- 2.PMID: 35685348 (2022) — Applications of Chinese Camellia oleifera and its By-Products: A Review. · Frontiers in chemistry
- 3.PMID: 28793800 (2017) — Anti-inflammatory and antioxidative effects of Camellia oleifera Abel components. · Future medicinal chemistry
- 4.PMID: 17188414 (2007) — Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
- 5.PMID: 26598814 (2015)